Cell Therapy Company Aims to Pioneer Analytics Automation
BlueRock says it’s helping advance the cell therapy industry by developing an automated system for analytical auditing. They say it’s among the few systems specifically designed for this application. The post Cell Therapy Company Aims to Pioneer Analytics Automation appeared first on GEN - Genetic Engineering and Biotechnology News .
BlueRock Therapeutics has unveiled an automated system for high-throughput auditing, specifically targeting the emerging class of cell therapies. According to Ronnie Lum, PhD, director of analytical and quality control, the system bridges a gap between available solutions and the requirements of cell therapy modalities. Unlike small molecules, cell therapies demand customized systems due to their smaller batch volumes.
The team has adapted existing tools for liquid handling and small sample processing, aiming to pioneer automation in this field. Collaborating with Hamilton Robotics, they have integrated the system into their analytical processes, with the goal of scaling up to commercial volumes. By reducing the need for extensive sample volumes, BlueRock expects to lower analytics costs across the industry.
They encourage other companies to collaborate in filling existing technological gaps, emphasizing their commitment to innovation in cell therapy analytics.
Written by urgent.news from GEN Biotechnology's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
